 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 April 1998 | Volume 128 Issue 8 | Pages 630-638
Background: Transesophageal echocardiography visualizes the left atrium and its appendage, thrombi, and spontaneous echocardiographic contrast.
Objective: To assess the association of transesophageal echocardiographic characteristics with stroke or embolism in atrial fibrillation.
Design: Multicenter observational follow-up study.
Setting: Hospitals in Austria and Slovakia.
Patients: 409 outpatients with nonrheumatic atrial fibrillation and without recent stroke.
Intervention: Patients with thrombi received anticoagulation, and patients without thrombi received aspirin.
Measurements: Primary events were stroke or embolism. Secondary events were death not caused by stroke or embolism and need for anticoagulation.
Results: In the left atrium or left atrial appendage, 10 patients (2.5%) had thrombi and 47 (12%) had spontaneous echocardiographic contrast. The appendage had a mean (±SD) length of 44 ± 10 mm, a mean width of 23 ± 6 mm, and a mean area of 5.8 ± 2.5 cm2. Follow-up ranged from 1 to 74 months (mean, 58 months). Fifty patients had stroke or embolism, 53 died of a cause other than stroke or embolism, and 38 required anticoagulation. On univariate analysis, thrombi (risk ratio, 3.9 [95% CI, 1.4 to 10.1]; P = 0.009), length of the left atrial appendage (risk ratio, 1.6 [CI, 1.05 to 2.5]; P = 0.03), and width of the left atrial appendage (risk ratio, 2.4 [CI, 1.2 to 4.8]; P = 0.01) were associated with stroke or embolism. Multivariate analysis identified hypertension (risk ratio, 3.6 [CI, 1.8 to 8.4]; P = 0.001), previous stroke (risk ratio, 3.7 [CI, 1.5 to 7.5]; P = 0.002), and age (risk ratio, 1.1 [CI, 1.0 to 1.1]; P < 0.001) as risk factors for stroke or embolism and provided evidence of an association between thrombi and stroke or embolism (risk ratio, 2.4 [CI, 0.9 to 6.9]; P = 0.09).
Conclusions: In outpatients with atrial fibrillation and without recent stroke, thrombi of the left atrium or left atrial appendage and length and width of the left atrial appendage were associated with stroke or embolism in univariate analysis. In a multivariate analysis, age, hypertension, and previous stroke were risk factors for stroke or embolism, and thrombi of the left atrium or left atrial appendage were possible risk factors. In these patients, history may be more useful than transesophageal echocardiography for the assessment of embolic risk.
Author and Article Information
for the ELAT Study Group.
ARTICLE
Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation
For author affiliations and current author addresses, see end of text.
For participants in the ELAT (Embolism in Left Atrial Thrombi) Study Group, see Appendix 1.
Grant Support: By the Fonds zur Forderung der Wissenschaftlichen Forschung, the Medizinisch-wissenschaftlicher Fonds des Burgermeisters, the Osterreichische Landerbank, and Wiener Stadtische Versicherung, Vienna, Austria.
Requests for Reprints: Claudia Stollberger, MD, Steingasse 31/18, A-1030 Vienna, Austria.
Current Author Addresses: Dr. Stollberger: Steingasse 31/18, A-1030 Vienna, Austria.
This article has been cited by other articles:
|
|
 |
|
  T. Kleemann, T. Becker, M. Strauss, S. Schneider, and K. Seidl Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score Eur J Echocardiogr, October 2, 2008; (2008) jen256v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Hohnloser, G. Z. Duray, U. Baber, and J. L. Halperin Prevention of stroke in patients with atrial fibrillation: current strategies and future directions Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H4 - H10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stollberger, J. Finsterer, and B. Schneider Arguments Against Left Atrial Appendage Occlusion for Stroke Prevention Stroke, September 1, 2007; 38(9): e77 - e77. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stollberger and J. Finsterer WATCHMAN for Stroke Prevention: An Out-of-Date Procedure J. Am. Coll. Cardiol., August 28, 2007; 50(9): 914 - 914. [Full Text] [PDF]
|
|
|
|
|
|
P. Sick Reply J. Am. Coll. Cardiol., August 28, 2007; 50(9): 914 - 915. [Full Text] [PDF]
|
|
|
|
 |
|
 The Stroke Risk in Atrial Fibrillation Working Gro Independent predictors of stroke in patients with atrial fibrillation: A systematic review Neurology, August 7, 2007; 69(6): 546 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): 700 - 752. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stollberger, B. Schneider, and J. Finsterer Stroke prevention by means of epicardial occlusion of the left atrial appendage J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 207 - 208. [Full Text] [PDF]
|
|
|
|
 |
|
 O. K. Mohrs, B. Nowak, S. E. Petersen, M. Welsner, C. Rubel, A. Magedanz, H.-U. Kauczor, and T. Voigtlaender Thrombus Detection in the Left Atrial Appendage Using Contrast-Enhanced MRI: A Pilot Study Am. J. Roentgenol., January 1, 2006; 186(1): 198 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Gage, C. van Walraven, L. Pearce, R. G. Hart, P. J. Koudstaal, B.S.P. Boode, and P. Petersen Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin Circulation, October 19, 2004; 110(16): 2287 - 2292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Brainin and C Stollberger Embolic stroke: the heart-brain connection reassessed J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1373 - 1373. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 429S - 456S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography Ann Intern Med, December 16, 2003; 139(12): 1018 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Singer A 60-Year-Old Woman With Atrial Fibrillation JAMA, October 22, 2003; 290(16): 2182 - 2189. [Full Text] [PDF]
|
|
|
|
|
|
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF]
|
|
|
|
|
|
A. L. Klein, R. D. Murray, and R. A. Grimm Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J. Am. Coll. Cardiol., March 1, 2001; 37(3): 691 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart and J. L. Halperin Atrial Fibrillation and Stroke : Concepts and Controversies Stroke, March 1, 2001; 32(3): 803 - 808. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Albers, J. E. Dalen, A. Laupacis, W. J. Manning, P. Petersen, and D. E. Singer Antithrombotic Therapy in Atrial Fibrillation Chest, January 1, 2001; 119(1_suppl): 194S - 206S. [Full Text] [PDF]
|
|
|
|
|
|
S. Stern, D. Altkorn, and W. Levinson Anticoagulation for Chronic Atrial Fibrillation JAMA, June 14, 2000; 283(22): 2901 - 2903. [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, D. G. Grosset, Q. Li, and K. R. Lees Identification Of Echocardiographic "Smoke" in a Bench Model With Transcranial Doppler Ultrasound Stroke, April 1, 2000; 31(4): 907 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pollick Left Atrial Appendage Myopathy : The Importance of Serial Transesophageal Assessment in Atrial Fibrillation Chest, February 1, 2000; 117(2): 297 - 298. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart and J. L. Halperin Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention Ann Intern Med, November 2, 1999; 131(9): 688 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.M. Channon and A.P. Banning Echocardiography in stroke and thromboembolism: transoesophageal imaging for all? QJM, November 1, 1999; 92(11): 619 - 621. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart, L. A. Pearce, R. McBride, R. M. Rothbart, and R. W. Asinger Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation : Analysis of 2012 Participants in the SPAF I–III Clinical Trials Stroke, June 1, 1999; 30(6): 1223 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Catherwood, W. D. Fitzpatrick, M. L. Greenberg, P. T. Holzberger, D. J. Malenka, B. R. Gerling, and J. D. Birkmeyer Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation Ann Intern Med, April 20, 1999; 130(8): 625 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Transesophageal Echocardiography in Atrial Fibrillation Journal Watch Cardiology, May 22, 1998; 1998(522): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Transesophageal Echocardiography in Chronic Atrial Fibrillation Journal Watch (General), May 1, 1998; 1998(501): 2 - 2. [Full Text]
|
|
Article
